Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
9.18
0.04 (0.38%)
At close: May 23, 2025, 3:59 PM
9.16
-0.22%
After-hours: May 23, 2025, 04:04 PM EDT
Cartesian Therapeutics Revenue
Cartesian Therapeutics reported an annual revenue of $38.91M, reflecting a 49.64% growth. For the quarter ending March 31, 2025, Cartesian Therapeutics generated $1.1M in revenue.
Revenue (ttm)
$38.91M
Revenue Growth
49.64%
Price / Sales Ratio
7.95
Revenue / Employee
$589.59K
Employees
66
Market Cap
238.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|